Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: A social network analysis

A. M. Young; R. J. Diclemente; D. S. Halgin; C. E. Sterk; J. R. Havens

doi:10.1007/s10461-014-0797-9

Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: A social network analysis

A. M. Young, R. J. Diclemente, D. S. Halgin, C. E. Sterk, J. R. Havens

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

This study examined feasibility of peer-based promotion of HIV vaccination and dyadic correlates to vaccine encouragement in risk- and non-risk networks of drug users (n = 433) in the US. Data were collected on HIV vaccine attitudes, risk compensation intentions, likelihood of encouraging vaccination, and recent (past 6 months) risk (i.e. involving sex and/or injecting drugs) and non-risk (i.e. involving co-usage of noninjected drugs and/or social support) relationships. Willingness to encourage HIV vaccination was reported in 521 and 555 risk- and non-risk relationships, respectively. However, 37 % expressed hesitancy, typically due to fear of side effects or social concerns. Encouragement was often motivated by perceived HIV risk, though 9 % were motivated by risk compensation intentions. In non-risk partnerships, encouragement was associated with drug co-usage, and in risk relationships, with perceived vaccine acceptability and encouragement by the partner. Network-based HIV vaccine promotion may be a successful strategy, but risk compensation intentions should be explored.

Original language	English
Pages (from-to)	1753-1763
Number of pages	11
Journal	AIDS and Behavior
Volume	18
Issue number	9
DOIs	https://doi.org/10.1007/s10461-014-0797-9
State	Published - Sep 2014

Bibliographical note

Funding Information:
Acknowledgments This work was supported by the National Institute on Drug Abuse [Grant numbers R01DA024598, R01DA033862 to J.R.H.] and the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health [Grant number UL1TR000117 to J.R.H]. The authors would like to acknowledge Hannah Cooper for her input during the conceptualization of the study and her thoughtful review of manuscript drafts.

Funding

Acknowledgments This work was supported by the National Institute on Drug Abuse [Grant numbers R01DA024598, R01DA033862 to J.R.H.] and the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health [Grant number UL1TR000117 to J.R.H]. The authors would like to acknowledge Hannah Cooper for her input during the conceptualization of the study and her thoughtful review of manuscript drafts.

Funders	Funder number
National Institutes of Health (NIH)
National Institute on Drug Abuse	R01DA033862, R01DA024598
National Center for Research Resources
National Center for Advancing Translational Sciences (NCATS)	UL1TR000117

Keywords

HIV vaccines
Injection drug use
Psychosocial
Rural health
Social networks

ASJC Scopus subject areas

Social Psychology
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10461-014-0797-9

Cite this

@article{810744e2475d4b58b74fb3736c5a767b,

title = "Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: A social network analysis",

abstract = "This study examined feasibility of peer-based promotion of HIV vaccination and dyadic correlates to vaccine encouragement in risk- and non-risk networks of drug users (n = 433) in the US. Data were collected on HIV vaccine attitudes, risk compensation intentions, likelihood of encouraging vaccination, and recent (past 6 months) risk (i.e. involving sex and/or injecting drugs) and non-risk (i.e. involving co-usage of noninjected drugs and/or social support) relationships. Willingness to encourage HIV vaccination was reported in 521 and 555 risk- and non-risk relationships, respectively. However, 37 % expressed hesitancy, typically due to fear of side effects or social concerns. Encouragement was often motivated by perceived HIV risk, though 9 % were motivated by risk compensation intentions. In non-risk partnerships, encouragement was associated with drug co-usage, and in risk relationships, with perceived vaccine acceptability and encouragement by the partner. Network-based HIV vaccine promotion may be a successful strategy, but risk compensation intentions should be explored.",

keywords = "HIV vaccines, Injection drug use, Psychosocial, Rural health, Social networks",

author = "Young, {A. M.} and Diclemente, {R. J.} and Halgin, {D. S.} and Sterk, {C. E.} and Havens, {J. R.}",

note = "Funding Information: Acknowledgments This work was supported by the National Institute on Drug Abuse [Grant numbers R01DA024598, R01DA033862 to J.R.H.] and the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health [Grant number UL1TR000117 to J.R.H]. The authors would like to acknowledge Hannah Cooper for her input during the conceptualization of the study and her thoughtful review of manuscript drafts.",

year = "2014",

month = sep,

doi = "10.1007/s10461-014-0797-9",

language = "English",

volume = "18",

pages = "1753--1763",

number = "9",

}

TY - JOUR

T1 - Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine

T2 - A social network analysis

AU - Young, A. M.

AU - Diclemente, R. J.

AU - Halgin, D. S.

AU - Sterk, C. E.

AU - Havens, J. R.

N1 - Funding Information: Acknowledgments This work was supported by the National Institute on Drug Abuse [Grant numbers R01DA024598, R01DA033862 to J.R.H.] and the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health [Grant number UL1TR000117 to J.R.H]. The authors would like to acknowledge Hannah Cooper for her input during the conceptualization of the study and her thoughtful review of manuscript drafts.

PY - 2014/9

Y1 - 2014/9

N2 - This study examined feasibility of peer-based promotion of HIV vaccination and dyadic correlates to vaccine encouragement in risk- and non-risk networks of drug users (n = 433) in the US. Data were collected on HIV vaccine attitudes, risk compensation intentions, likelihood of encouraging vaccination, and recent (past 6 months) risk (i.e. involving sex and/or injecting drugs) and non-risk (i.e. involving co-usage of noninjected drugs and/or social support) relationships. Willingness to encourage HIV vaccination was reported in 521 and 555 risk- and non-risk relationships, respectively. However, 37 % expressed hesitancy, typically due to fear of side effects or social concerns. Encouragement was often motivated by perceived HIV risk, though 9 % were motivated by risk compensation intentions. In non-risk partnerships, encouragement was associated with drug co-usage, and in risk relationships, with perceived vaccine acceptability and encouragement by the partner. Network-based HIV vaccine promotion may be a successful strategy, but risk compensation intentions should be explored.

AB - This study examined feasibility of peer-based promotion of HIV vaccination and dyadic correlates to vaccine encouragement in risk- and non-risk networks of drug users (n = 433) in the US. Data were collected on HIV vaccine attitudes, risk compensation intentions, likelihood of encouraging vaccination, and recent (past 6 months) risk (i.e. involving sex and/or injecting drugs) and non-risk (i.e. involving co-usage of noninjected drugs and/or social support) relationships. Willingness to encourage HIV vaccination was reported in 521 and 555 risk- and non-risk relationships, respectively. However, 37 % expressed hesitancy, typically due to fear of side effects or social concerns. Encouragement was often motivated by perceived HIV risk, though 9 % were motivated by risk compensation intentions. In non-risk partnerships, encouragement was associated with drug co-usage, and in risk relationships, with perceived vaccine acceptability and encouragement by the partner. Network-based HIV vaccine promotion may be a successful strategy, but risk compensation intentions should be explored.

KW - HIV vaccines

KW - Injection drug use

KW - Psychosocial

KW - Rural health

KW - Social networks

UR - http://www.scopus.com/inward/record.url?scp=84906307312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906307312&partnerID=8YFLogxK

U2 - 10.1007/s10461-014-0797-9

DO - 10.1007/s10461-014-0797-9

M3 - Article

C2 - 24849621

AN - SCOPUS:84906307312

SN - 1090-7165

VL - 18

SP - 1753

EP - 1763

JO - AIDS and Behavior

JF - AIDS and Behavior

IS - 9

ER -

Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: A social network analysis

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this